Existing regulatory frameworks for foods and supplements are not appropriate for Cannabidiol
USA
Jan 30, 2023
Given the growing cannabidiol (CBD) products market, the U.S. Food and Drug Administration convened a high-level internal working group to explore potential regulatory pathways for CBD products.
The FDA has concluded that a new regulatory pathway for CBD is needed that balances individuals’ desire for access to CBD products with the regulatory oversight needed to manage risks. The agency is prepared to work with Congress on this matter. Today, we are also denying three citizen petitions that had asked the agency to conduct rulemaking to allow the marketing of CBD products as dietary supplements.
For further information (in English), click on the Link
FSA to review progress on CBD novel food applications
UK
Dec 05, 2024
TSJ authorized the use of cannabis for medicinal, pharmaceutical and industrial purposes
Brazil
Nov 15, 2024
Ministry of Health proposes CBD requirements in food for human consumption
Colombia
Oct 08, 2024
FDA and FTC issue warning letters for marketing imitation food products containing Delta-8 THC
USA
Jul 19, 2024
Costa Rica regulates cannabis and hemp use in food
Costa Rica
Jun 27, 2024
South Korea prohibits THC or CBD in labeling and advertising of food products
South Korea
Jun 18, 2024
Canada proposes amendments to cannabis regulations
Canada
Jun 17, 2024
Hemp seeds authorized for use in foodstuffs
Argentina
Dec 07, 2023
New Online Platform for the Management of Cannabis Derivatives Manufacturing Licenses
Colombia
Nov 09, 2023
The FSA updates recommendations on foods with CBD
UK
Oct 12, 2023
New regulation on medical cannabis and industrial hemp published
Argentina
Aug 08, 2023
Hemp-derived CBD products to be authorized soon
USA
Jul 20, 2023
Hemp seeds and hemp derived products to be regulated soon
Argentina
Jul 18, 2023
MFDS bans 9 substances in food
South Korea
Jun 14, 2023
Prime Minister disagrees with CBD prohibition bill
Czech Republic
May 17, 2023
